secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001628280-26-001603
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Labs announces CEO transition: Foster to step down, Girshick to become CEO effective May 5, 2026
--------------------------------------------------------------------------------

- James C. Foster to step down as CEO and Chairman; Birgit Girshick (COO) to become CEO effective May 5, 2026.
- Board size increases from 11 to 12; Dr. Martin Mackay to become Chair; Girshick nominated to Board.
- Girshick's base salary increases to $1,200,000, target incentive 100% of salary; initial equity grant $9M (80% PSU/20% RSU).
- Foster receives $3M RSU grant; expected to remain non-executive director post-transition.
- Elliott Management provides limited consent for Board size increase under May 2025 cooperation agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000162828026001603/0001628280-26-001603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000162828026001603/crl-20260108.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-001603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer